OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instrument...
OrbusNeich Medical Group schedules board meeting to review interim results
OrbusNeich Launches Pivotal Japan Trial for Coronary Drug-Coated Balloon
OrbusNeich targets end-2027 completion of Japan trial enrollment for proprietary drug-coated balloon
Pre-market trend | ORBUSNEICH (6929.HK) 5/11 Medical devices warming up, are low-level bullish signals emerging?
OrbusNeich Medical Group Holdings Limited (6929) Gets a Buy from CICC
ORBUSNEICH's final dividend is expected to increase by 20% to 12 cents, planning to declare a regular interim dividend